Roche Diagnostics launches new Elecsys Troponin assay

Roche has announced the availability of its new Elecsys Troponin T high sensitive (TnT hs) assay, which is designed to be used on cobas and MODULAR Analytics serum work areas.

The product is being made available to healthcare centres in the UK and Ireland and is a highly-sensitive diagnostic assay has been developed to improve the detection and exclusion of myocardial injury in its early stages.

It demonstrates precision in the range of 0.003-10 ng/ml Troponin T in serum or plasma, helping surgeons to identify the risk of future coronary events.

“Until recently, assays were limited by a lack of sensitivity at the time of presentation and a lack of precision at the lower concentrations above the 99th percentile,” explained Dr Richard Body, an emergency medicine specialist at Manchester Royal Infirmary.

However, he added, the Elecsys TnT hs assay has the scope to address both of these problems.

Another Roche Diagnostic product launched this year – its test for preeclampsia – was described as an “important milestone” for female health.